1 Min Read
Sept 29 (Reuters) - Ibio Inc :
* Successful application of proprietary technologies to achieve first milestone in commercial development agreement with Azargen Biotechnologies Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.